Stephen Kok studied Chemical Biology at the University of California, Berkeley and in 2012 he joined Genentech developing trace metal analyses and multi-dimensional liquid chromatography methods in pursuit of characterizing antibody-based biotherapeutics. He subsequently joined Sutro Biopharma where he managed the chromatography team as a subject matter expert, and in 2022 joined the Genedata Scientific Team. At Genedata, Stephen consults for many of the Top 25 Biopharma companies to help develop and implement high-throughput MS-based data processing solutions to support the high volume of data acquisition required to characterize next-generation biotherapeutic modalities.